Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Albany · SciRah

Researcher profile · Semantic Scholar

C. Albany

Share profile

C. Albany — researcher profile on SciRah

h-index: 28
Works: 139
Citations: 3,008

Most-cited papers

Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium
S. Gillessen, N. Sauvé, L. Collette, G. Daugaard +30 more
2021Journal of Clinical Oncology205 citations Open access
Semantic Scholar
Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012.
M. Hussain, S. Daignault-Newton, P. Twardowski, C. Albany +21 more
2017Journal of Clinical Oncology187 citations Open access
Semantic Scholar
Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: a Hoosier Cancer Research Network Study GU14-206
N. Adra, L. Einhorn, S. Althouse, N. Ammakkanavar +4 more
2018Annals of Oncology178 citations Open access
Semantic Scholar
Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium
J. Beyer, L. Collette, N. Sauvé, G. Daugaard +37 more
2021Journal of Clinical Oncology156 citations Open access
Semantic Scholar
High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University Experience.
N. Adra, R. Abonour, S. Althouse, C. Albany +2 more
2017Journal of Clinical Oncology151 citations Open access
Semantic Scholar
Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes.
M. Galsky, Huan Wang, N. Hahn, P. Twardowski +21 more
2017European Urology112 citations
Semantic Scholar
Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer.
E. Antonarakis, S. Tagawa, Giuseppe Galletti, D. Worroll +23 more
2017Journal of Clinical Oncology77 citations Open access
Semantic Scholar
Olanzapine for the Treatment of Advanced Cancer-Related Chronic Nausea and/or Vomiting: A Randomized Pilot Trial.
R. Navari, Cameron M. Pywell, J. Le-Rademacher, P. White +3 more
2020JAMA Oncology70 citations Open access
Semantic Scholar
Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine
C. Albany, Mary P. Hever-Jardine, Katherine M. von Herrmann, Christina Y. Yim +13 more
2016OncoTarget70 citations Open access
Semantic Scholar
Management of stage I testicular germ cell tumours
M. Chovanec, N. Hanna, K. Cary, L. Einhorn +1 more
2016Nature reviews. Urology62 citations
Semantic Scholar
Practice Makes Perfect: The Rest of the Story in Testicular Cancer as a Model Curable Neoplasm.
T. Tandstad, C. Kollmannsberger, B. Roth, C. Jeldres +19 more
2017Journal of Clinical Oncology50 citations Open access
Semantic Scholar
Treatment of CD30-Expressing Germ Cell Tumors and Sex Cord Stromal Tumors with Brentuximab Vedotin: Identification and Report of Seven Cases.
C. Albany, L. Einhorn, L. Garbo, T. Boyd +2 more
2018The Oncologist48 citations Open access
Semantic Scholar
Differential Activity of PARP Inhibitors in BRCA1- Versus BRCA2-Altered Metastatic Castration-Resistant Prostate Cancer
F. Taza, Albert E. Holler, W. Fu, Hao Wang +22 more
2021JCO Precision Oncology45 citations Open access
Semantic Scholar
Clinical Correlates of Benefit From Radium‐223 Therapy in Metastatic Castration Resistant Prostate Cancer
A. Alva, L. Nordquist, S. Daignault, S. George +9 more
2017The Prostate43 citations Open access
Semantic Scholar
A phase Ib/II study of neoadjuvant pembrolizumab (pembro) and chemotherapy for locally advanced urothelial cancer (UC).
C. Hoimes, C. Albany, J. Hoffman-Censits, M. Fleming +15 more
2018Annals of Oncology41 citations Open access
Semantic Scholar
Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer
C. Sweeney, I. Percent, S. Babu, J. Cultrera +15 more
2022Clinical Cancer Research40 citations Open access
Semantic Scholar
Hypermethylation and global remodelling of DNA methylation is associated with acquired cisplatin resistance in testicular germ cell tumours
Zeeshan Fazal, Ratnakar Singh, F. Fang, E. Bikorimana +11 more
2020Epigenetics39 citations Open access
Semantic Scholar
A phase 1 study of combined guadecitabine and cisplatin in platinum refractory germ cell cancer
C. Albany, Zeeshan Fazal, Ratnakar Singh, E. Bikorimana +10 more
2020Cancer Medicine39 citations Open access
Semantic Scholar
Cisplatin-associated neuropathy characteristics compared to those associated with other neurotoxic chemotherapy agents (Alliance A151724)
C. Albany, T. Dockter, E. Wolfe, J. Le-Rademacher +9 more
2020Supportive Care in Cancer31 citations Open access
Semantic Scholar
Systemic immune-inflammation index in germ-cell tumours: search for a biological prognostic biomarker
C. Albany
2018British Journal of Cancer27 citations Open access
Semantic Scholar
Emerging Prognostic Biomarkers in Testicular Germ Cell Tumors: Looking Beyond Established Practice
M. Chovanec, C. Albany, M. Mego, R. Montironi +2 more
2018Frontiers in Oncology26 citations Open access
Semantic Scholar
Targeting of Deregulated Wnt/β-Catenin Signaling by PRI-724 and LGK974 Inhibitors in Germ Cell Tumor Cell Lines
S. Schmidtova, K. Kalavska, V. Lišková, Jana Plava +10 more
2021International Journal of Molecular Sciences24 citations Open access
Semantic Scholar
Testicular cancer: The usage of central review for pathology diagnosis of orchiectomy specimens.
Saul E Harari, D. Sassoon, David S. Priemer, J. Jacob +11 more
2017Urologic oncology24 citations
Semantic Scholar
A Suggested Prognostic Reclassification of Intermediate and Poor‐Risk Nonseminomatous Germ Cell Tumors
A. Necchi, G. Pond, N. Nicolai, P. Giannatempo +6 more
2017Clinical Genitourinary Cancer23 citations
Semantic Scholar
Abiraterone + prednisone (Abi) +/- veliparib (Vel) for patients (pts) with metastatic castration-resistant prostate cancer (CRPC): NCI 9012 updated clinical and genomics data.
M. Hussain, S. Daignault, P. Twardowski, C. Albany +16 more
201723 citations
Semantic Scholar
Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma.
S. Fischer, T. Tandstad, G. Cohn-Cedermark, C. Thibault +20 more
2019Journal of Clinical Oncology21 citations Open access
Semantic Scholar
Management of Residual Mass in Germ Cell Tumors After Chemotherapy
C. Albany, K. Kesler, C. Cary
2019Current Oncology Reports19 citations
Semantic Scholar
Long‐Term Survival of Good‐Risk Germ Cell Tumor Patients After Postchemotherapy Retroperitoneal Lymph Node Dissection: A Comparison of BEP × 3 vs. EP × 4 and Treating Institution
C. Cary, J. Jacob, C. Albany, T. Masterson +3 more
2017Clinical Genitourinary Cancer18 citations
Semantic Scholar
Life-Threatening Docetaxel Toxicity in a Patient With Reduced-Function CYP3A Variants: A Case Report
Nicholas R. Powell, Tyler Shugg, Reynold C. Ly, C. Albany +3 more
2022Frontiers in Oncology16 citations Open access
Semantic Scholar
Co-targeting androgen receptor (AR) and DNA repair: A randomized ETS gene fusion-stratified trial of abiraterone + prednisone (Abi) +/- the PARP1 inhibitor veliparib for metastatic castration-resistant prostate cancer (mCRPC) patients (pts) (NCI9012)--A University of Chicago phase II consortium tria
M. Hussain, S. Daignault, P. Twardowski, C. Albany +16 more
201616 citations
Semantic Scholar
Immunomodulation by HDAC inhibition: Results from a phase Ib study with vorinostat and pembrolizumab in metastatic urothelial, renal, and prostate carcinoma patients.
R. Pili, D. Quinn, C. Albany, N. Adra +11 more
2019Journal of Clinical Oncology15 citations
Semantic Scholar
Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors
Ryan Ashkar, D. Feldman, N. Adra, M. Zaid +10 more
2021Investigational new drugs14 citations Open access
Semantic Scholar
Prognostic factors in advanced seminoma: An analysis from the IGCCCG Update Consortium.
Joerg Beyer, L. Collette, G. Daugaard, R. de Wit +16 more
202014 citations
Semantic Scholar
The prognostic impact of different tumor marker levels in nonseminomatous germ cell tumor patients with intermediate prognosis: A registry of the International Global Germ Cell Tumor Collaborative Group (G3).
C. Seidel, G. Daugaard, A. Tryakin, A. Necchi +10 more
2019Urologic oncology13 citations Open access
Semantic Scholar
Risk of Bleomycin-Related Pulmonary Toxicities and Operative Morbidity After Postchemotherapy Retroperitoneal Lymph Node Dissection in Patients With Good-Risk Germ Cell Tumors.
A. Calaway, R. Foster, N. Adra, T. Masterson +4 more
2018Journal of Clinical Oncology13 citations Open access
Semantic Scholar
PD52-03 A MULTICENTER PHASE 1B/2 STUDY OF NEOADJUVANT PEMBROLIZUMAB AND CISPLATIN CHEMOTHERAPY FOR MUSCLE INVASIVE UROTHELIAL CANCER
Hristos Z. Kaimakliotis, C. Albany, J. Hoffman-Censits, E. Trabulsi +15 more
2019Journal of Urology12 citations Open access
Semantic Scholar
Neoadjuvant chemotherapy in urothelial bladder cancer: impact of regimen and variant histology.
Hristos Z. Kaimakliotis, M. Monn, Jane S. Cho, J. Pedrosa +9 more
2016Future Oncology12 citations
Semantic Scholar
Low CD34+ Cell Doses Are Associated with Increased Cost and Worse Outcome after Tandem Autologous Stem Cell Transplantation in Patients with Relapsed or Refractory Germ Cell Tumors.
M. Hyder, W. Goebel, Kirsten D. Ervin, J. Schwartz +4 more
2018Biology of Blood and Marrow Transplantation10 citations Open access
Semantic Scholar
PACIFIC trial: A randomized phase II study of apatorsen and abiraterone in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) who have had PSA progression while receiving abiraterone (ABI).
K. Chi, M. Fleming, K. Sunderland, C. Albany +9 more
201710 citations
Semantic Scholar
A randomized phase IIa study of quantified bone scan response in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 dichloride alone or in combination with abiraterone acetate/prednisone or enzalutamide
D. Petrylak, U. Vaishampayan, K. Patel, C. Higano +9 more
2021ESMO Open9 citations Open access
Semantic Scholar
Prognostic Value of Teratoma in Primary Tumor and Postchemotherapy Retroperitoneal Lymph Node Dissection Specimens in Patients With Metastatic Germ Cell Tumor.
F. Taza, M. Chovanec, A. Snavely, N. Hanna +6 more
2020Journal of Clinical Oncology9 citations Open access
Semantic Scholar
Phase 1b/2 study of enzalutamide (ENZ) with LY3023414 (LY) or placebo (PL) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) after progression on abiraterone.
C. Sweeney, I. Percent, S. Babu, J. Cultrera +16 more
2019Journal of Clinical Oncology9 citations
Semantic Scholar
Incorporating DNA Methyltransferase Inhibitors (DNMTis) in the Treatment of Genitourinary Malignancies: A Systematic Review
M. Chovanec, F. Taza, M. Kalra, N. Hahn +3 more
2018Targeted oncology9 citations Open access
Semantic Scholar
Intermediate prognosis in metastatic germ cell tumours-outcome and prognostic factors.
C. Seidel, G. Daugaard, A. Tryakin, A. Necchi +9 more
2018European Journal of Cancer9 citations
Semantic Scholar
Phase II trial of pembrolizumab in patients (pts) with incurable platinum refractory germ cell tumors (GCT).
N. Adra, S. Althouse, N. Ammakkanavar, Milan Radovich +4 more
20179 citations
Semantic Scholar
Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study
N. Adra, C. Albany, M. Brames, Somer Case-Eads +8 more
2016Supportive Care in Cancer9 citations Open access
Semantic Scholar
Survival outcomes of patients with metastatic germ cell tumor (mGCT) treated from 1998 to 2012: The Indiana University (IU) experience.
N. Adra, K. Ku, M. Kalra, S. Althouse +3 more
20168 citations
Semantic Scholar
Prognostic Effect of Carcinoma In Situ in Muscle-invasive Urothelial Carcinoma Patients Receiving Neoadjuvant Chemotherapy
Derek E. Thomas, Hristos Z. Kaimakliotis, K. Rice, J. A. Pereira +18 more
2016Clinical Genitourinary Cancer8 citations Open access
Semantic Scholar
Molecular Characterization of Testicular Germ Cell Tumors Using Tissue Microdissection.
Liang Cheng, S. Mann, A. López-Beltran, M. Chovanec +8 more
2021Methods in molecular biology6 citations
Semantic Scholar
Fluorescence In Situ Hybridization (FISH) Detection of Chromosomal 12p Anomalies in Testicular Germ Cell Tumors.
Liang Cheng, D. Davidson, R. Montironi, Ming-Sheng Wang +4 more
2020Methods in molecular biology6 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

N. Adra×15
Invite
N. Adra — researcher profile on SciRah
L. Einhorn×15
Invite
L. Einhorn — researcher profile on SciRah
N. Hanna×12
Invite
N. Hanna — researcher profile on SciRah
M. Chovanec×8
Invite
M. Chovanec — researcher profile on SciRah

×7

Invite

A. Necchi — researcher profile on SciRah

Invite

R. Foster — researcher profile on SciRah

T. Masterson×7

Invite

T. Masterson — researcher profile on SciRah

Invite

O. Ståhl — researcher profile on SciRah

Invite

D. Feldman — researcher profile on SciRah

Invite

C. Cary — researcher profile on SciRah

Invite

Liang Cheng — researcher profile on SciRah

S. Gillessen×5

Invite

S. Gillessen — researcher profile on SciRah